Demographic, clinical and laboratory characteristics for differential diagnosis of peripheral lymphadenopathy (LAP) and the etiologic distribution of LAP in adults; a multicenter, nested case-control study including 1401 patients from Turkey.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 20 12 2020
accepted: 19 02 2021
pubmed: 18 3 2021
medline: 30 11 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Peripheral lymphadenopathy (LAP) is an important and common abnormal finding of the physical exam in general medical practice. We aimed to reveal the LAP etiology and demographic, clinical and laboratory variables that may be useful in the differential evaluation of LAP. This multicenter, nested case-control study including 1401 patients between 2014 and 2019 was conducted in 19 tertiary teaching and research hospitals from different regions in Turkey. The ratio of infectious, malign and autoimmune/inflammatory diseases was 31.3%, 5% and 0.3%, respectively. In 870 (62%) of patients had nonspecific etiology. Extrapulmonary tuberculosis (n: 235, 16.8%) was the most frequent cause of LAP. The ratio of infective etiology of LAP was significantly lower in patients older than 65 years-old compared to younger patients with the rate of 66.67% and 83.84%, respectively (p 0.016, OR 0.386, 95% Cl 0.186-0.803). The probability of malign etiology was higher both in patients who are older than 45 years-old (p < 0.001, OR 3.23, 95% Cl 1.99-5.26) and older than 65 years-old (p 0.002, OR 3.36, 95% Cl 1.69-6.68). Age, localization and duration of LAP, leukocytosis, anemia, thrombocytopenia, CRP and sedimentation rate were important parameters to differentiate infections. Size of lymph node and splenomegaly in addition to the parameters above were useful parameters for differentiating malign from benign etiology. Despite the improvements in diagnostic tools, reaching a definite differential diagnosis of lymphadenopathy is still challenging. Our results may help clinicians to decide in which cases they need an aggressive workup and set strategies on optimizing the diagnostic approach of adulthood lymphadenopathy.

Identifiants

pubmed: 33728579
doi: 10.1007/s11739-021-02683-2
pii: 10.1007/s11739-021-02683-2
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2139-2153

Informations de copyright

© 2021. Società Italiana di Medicina Interna (SIMI).

Références

Freeman AM, Matto P. Adenopathy (2020) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513250/ . Updated 2020 Jul 10
Gaddey HL, Riegel AM (2016) Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician 94(11):896–903
pubmed: 27929264
Prudent E, La Scola B, Drancourt M, Angelakis E, Raoult D (2018) Molecular strategy for the diagnosis of infectious lymphadenitis. Eur J Clin Microbiol Infect Dis 37(6):1179–1186. https://doi.org/10.1007/s10096-018-3238-2
doi: 10.1007/s10096-018-3238-2 pubmed: 29594802
Monaco SE, Khalbuss WE, Pantanowitz L (2012) Benign non-infectious causes of lymphadenopathy: a review of cytomorphology and differential diagnosis. Diagn Cytopathol 40(10):925–938. https://doi.org/10.1002/dc.21767
doi: 10.1002/dc.21767 pubmed: 22351626
Mohan A, Reddy MK, Phaneendra BV, Chandra A (2007) Aetiology of peripheral lymphadenopathy in adults: analysis of 1724 cases seen at a tertiary care teaching hospital in southern India. Natl Med J India 20(2):78–80
pubmed: 17802986
Qadri SK, Hamdani NH, Besina S, Makhdoomi R, Rasool R et al (2016) Cytological study of cervical lymphadenopathy in a trtiary care institution from Kashmir Valley. India J Cytol Histol 7:418. https://doi.org/10.4172/2157-7099.1000418
doi: 10.4172/2157-7099.1000418
Al-Tawfiq JA, Raslan W (2012) The analysis of pathological findings for cervical lymph node biopsies in eastern Saudi Arabia. J Infect Public Health 5(2):140–144. https://doi.org/10.1016/j.jiph.2011.11.006
doi: 10.1016/j.jiph.2011.11.006 pubmed: 22541260
Gul M, Aliosmanoglu I, Turkoglu A, Dal S, Tas I, Bac B (2013) Peripheral lymphadenopathy in adults: results of 67 cases of excisional biopsy. Dicle Med J 40(2):245–249. https://doi.org/10.5798/diclemedj.0921.2013.02.0263
doi: 10.5798/diclemedj.0921.2013.02.0263
Ashfaq M, Ahmad N, Ullah I, Iqbal MJ (2006) Cervical lymphadenopathy: diagnostic approach. J Postgrad Med Inst 20(4):374–378
Mert A, Tabak F, Ozaras R, Tahan V, Oztürk R, Aktuğlu Y (2002) Tuberculous lymphadenopathy in adults: a review of 35 cases. Acta Chir Belg 102(2):118–121. https://doi.org/10.1080/00015458.2002.11679277
doi: 10.1080/00015458.2002.11679277 pubmed: 12051084
Golden MP, Vikram HR (2005) Extrapulmonary tuberculosis: an overview. Am Fam Physician 72(9):1761–1768
pubmed: 16300038
Lee Y, Terry R, Lukes RJ (1980) Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol 14(1):53–60. https://doi.org/10.1002/jso.2930140108
doi: 10.1002/jso.2930140108 pubmed: 7382513
Khajanchi M, Bambarkar S, Gadgil A, Roy N (2016) Cervical node tuberculosis in adults of an urban middle class community: incidence and management. Indian J Otolaryngol Head Neck Surg 68(3):345–351. https://doi.org/10.1007/s12070-015-0832-9
doi: 10.1007/s12070-015-0832-9 pubmed: 27508138
Fijten GH, Blijham GH (1988) Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians’ workup. J Fam Pract 27(4):373–376. https://doi.org/10.1080/09503158808416945
doi: 10.1080/09503158808416945 pubmed: 3049914
Darnal HK, Karim N, Kamini K, Angela K (2005) The profile of lymphadenopathy in adults and children. Med J Malays 60(5):590–598
Özkan EA, Göret CC, Özdemir ZT, Yanık S, Göret NE, Doğan M, Cihan FG, Akkoca AN (2015) Evaluation of peripheral lymphadenopathy with excisional biopsy: six-year experience. Int J Clin Exp Pathol 8(11):15234–15239
pubmed: 26823872 pmcid: 4713658
Shrestha AL, Shrestha P (2018) Peripheral lymph node excisional biopsy: yield, relevance, and outcomes in a remote surgical setup. Surg Res Pract 2018:8120390. https://doi.org/10.1155/2018/8120390
doi: 10.1155/2018/8120390 pubmed: 29756005 pmcid: 5883987
Ferrer RL (2020) Evaluation of peripheral lymphadenopathy in adults. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. Accessed on 25 Nov 2020
Jung W, Trümper L (2008) Differenzialdiagnose und -abklärung von Lymphknotenvergrösserungen [Differential diagnosis and diagnostic strategies of lymphadenopathy]. Der Internist 49(3):305–320. https://doi.org/10.1007/s00108-008-2016-0
doi: 10.1007/s00108-008-2016-0 pubmed: 18273586
Walsh R, Kornguth PJ, Soo MS, Bentley R, DeLong DM (1997) Axillary lymph nodes: mammographic, pathologic, and clinical correlation. AJR Am J Roentgenol 168(1):33–38. https://doi.org/10.2214/ajr.168.1.8976915
doi: 10.2214/ajr.168.1.8976915 pubmed: 8976915
Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P (1993) Clinical approach to lymphadenopathy. Semin Oncol 20(6):570–582
pubmed: 8296196
Watson J, Salisbury C, Banks J, Whiting P, Hamilton W (2019) Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records. Br J Cancer 120(11):1045–1051. https://doi.org/10.1038/s41416-019-0458-x
doi: 10.1038/s41416-019-0458-x pubmed: 31015558 pmcid: 6738065

Auteurs

Ercan Yenilmez (E)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, 34668, Uskudar, Istanbul, Turkey. ercanyenilmez79@gmail.com.

Yıldız Verdi (Y)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Ayca Ilbak (A)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, 34668, Uskudar, Istanbul, Turkey.

Burcu Caliskan Demirkiran (BC)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey.

Zehra Duman (Z)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Fatma Bozkurt (F)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.

Derya Seyman (D)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.

Ali Asan (A)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.

Halime Betul Sahin Eker (HBS)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Adana City Hospital, Adana, Turkey.

Mehmet Resat Ceylan (MR)

Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Harran University, Sanliurfa, Turkey.

Salih Emre (S)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Prof. Dr. Cemil Tascıoglu City Hospital, Istanbul, Turkey.

Gozde Ozturk Altunyurt (GO)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Kartal Lutfi Kirdar City Hospital, Istanbul, Turkey.

Saliha Ayan (S)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

Emine Parlak (E)

Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ataturk University, Erzurum, Turkey.

Goknur Yapar Toros (GY)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Onkoloji Training and Research Hospital, Ankara, Turkey.

Gulsen Yoruk (G)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, İstanbul Training and Research Hospital, Istanbul, Turkey.

Mehmet Ceylan (M)

Department of Infectious Diseases and Clinical Microbiology, Bakircay University, Cigli Training and Research Hospital, Izmir, Turkey.

Leman Karaagac (L)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Mehmet Akif Inan Training and Research Hospital, Sanliurfa, Turkey.

Muge Ozguler (M)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Fethi Sekin City Hospital, Elazığ, Turkey.

Busra Meral (B)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.

Muzeyyen Ay (M)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.

Cinar Ozturk (C)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.

Zehra Karacaer (Z)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey.

Ersin Tural (E)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, 34668, Uskudar, Istanbul, Turkey.

Rıza Aytac Cetinkaya (RA)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, 34668, Uskudar, Istanbul, Turkey.

Ilyas Dokmetas (I)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Sukran Kose (S)

Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Tepecik Training and Research Hospital, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH